$3.51-0.06 (-1.68%)
Advanced Flower Capital Inc.
Advanced Flower Capital Inc. in the Financial Services sector is trading at $3.51 with a market capitalization of $82M. Wall Street consensus targets $8.00 (1 analysts), implying a +127.9% move over the next 12 months. The stock is currently 29% below its 52-week high of $4.93, remaining 24.0% above its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality. The Whystock Score of 75/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $13.41M↑ | $7.99M↑ | -$3.90M↓ | $4.47M↓ | $5.14M |
| Gross Profit | — | — | — | — | — |
| Operating Income | — | — | — | — | — |
| Net Income | $11.43M↑ | $914,046↑ | -$12.49M↑ | -$13.16M↓ | $4.07M |
Advanced Flower Capital Inc. originates, structures, underwrites, invests in, and manages senior secured loans and other types of mortgage loans and debt securities for established companies operating in the cannabis industry. It primarily originates...

NAV climbed to $8.25 per share as management navigates cannabis sector stress.
Net investment income covers dividend threefold, while strategic repurchases and a robust pipeline signal confidence despite legacy cannabis portfolio challenges.

Moby summary of Advanced Flower Capital Inc.'s Q2 2026 earnings call

AFC Gamma (NASDAQ:AFCG) reported second-quarter net investment income of $3.5 million, or $0.15 per weighted average common share, while emphasizing opportunities to deploy capital in the lower middle-market private credit sector as lenders retreat amid broader market stress. The company’s board de
Gladstone Investment (GAIN) delivered earnings and revenue surprises of +8.33% and +10.46%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?